Westside Investment Management’s Quince Therapeutics QNCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $124 | Hold |
75
| – | – | ﹤0.01% | 1270 |
|
|
2025
Q1 | $100 | Hold |
75
| – | – | ﹤0.01% | 968 |
|
|
2024
Q4 | $140 | Hold |
75
| – | – | ﹤0.01% | 972 |
|
|
2024
Q3 | $58 | Hold |
75
| – | – | ﹤0.01% | 981 |
|
|
2024
Q2 | $56 | Hold |
75
| – | – | ﹤0.01% | 976 |
|
|
2024
Q1 | $80 | Hold |
75
| – | – | ﹤0.01% | 889 |
|
|
2023
Q4 | $79 | Hold |
75
| – | – | ﹤0.01% | 857 |
|
|
2023
Q3 | $84 | Hold |
75
| – | – | ﹤0.01% | 830 |
|
|
2023
Q2 | $113 | Hold |
75
| – | – | ﹤0.01% | 828 |
|
|
2023
Q1 | $117 | Hold |
75
| – | – | ﹤0.01% | 826 |
|
|
2022
Q4 | $0 | Hold |
75
| – | – | ﹤0.01% | 842 |
|
|
2022
Q3 | $0 | Hold |
75
| – | – | ﹤0.01% | 843 |
|
|
2022
Q2 | $0 | Hold |
75
| – | – | ﹤0.01% | 830 |
|
|
2022
Q1 | $0 | Hold |
75
| – | – | ﹤0.01% | 807 |
|
|
2021
Q4 | $0 | Hold |
75
| – | – | ﹤0.01% | 789 |
|
|
2021
Q3 | $6 | Hold |
75
| – | – | ﹤0.01% | 633 |
|
|
2021
Q2 | $3 | Hold |
75
| – | – | ﹤0.01% | 696 |
|
|
2021
Q1 | $2 | Hold |
75
| – | – | ﹤0.01% | 688 |
|
|
2020
Q4 | $2 | Hold |
75
| – | – | ﹤0.01% | 612 |
|
|
2020
Q3 | $3 | Buy |
+75
| New | +$3 | ﹤0.01% | 596 |
|